Arman Qamar: We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn:
“We are routinely evaluating VTE PRS in the clinic in many of our patients with unprovoked VTE. We discuss the evolving science in our recent review.”
Quoting RPTH Journal post:
“Recent studies demonstrate that polygenic risk score (PRS) significantly improves VTE risk prediction beyond traditional clinical factors. Recent findings indicate that PRS could inform thromboprophylaxis decisions for high-risk patients.”
Title: Role of polygenic risk scores in venous thromboembolism: current state and future directions
Authors: Aman Goyal, Sonia Hurjkaliani, Kevin Michael Alexander, Jianfeng Xu, Manan Pareek, Arman Qamar
Read full article here.
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 15:58Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke